Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement

Area of Science:

• Neuroscience
• Developmental Biology
• Epilepsy Research

Background:

• Focal cortical dysplasia (FCD) is a leading cause of drug-resistant epilepsy and cognitive impairments.
• The role of neuronal misplacement in FCD-associated seizure generation remains unclear.
• Understanding FCD pathogenesis is critical for developing effective epilepsy treatments.

Purpose of the Study:

• To investigate whether neuronal misplacement and white matter heterotopia are necessary for seizure activity in a murine model of type II FCD.
• To determine the necessity of FCD-related developmental defects for seizure generation.
• To explore potential therapeutic strategies for FCD-associated epilepsy.

Main Methods:

• Generation of a murine model of type II FCD by increasing mTOR activity in layer 2/3 neurons.
• Administration of rapamycin from birth to prevent FCD-related defects, including neuronal misplacement.
• Utilizing inducible vectors to bypass neuronal misplacement and heterotopia.
• Monitoring seizure activity and survival rates.

Main Results:

• Dyslamination and white matter heterotopia were not essential for seizure generation in the FCD model.
• Experimental FCDs induced tonic-clonic seizures with normal survival rates.
• Rapamycin treatment eliminated seizures by preventing developmental defects but seizures recurred upon withdrawal.
• Bypassing neuronal misplacement did not prevent seizure occurrence.

Conclusions:

• Neuronal misplacement and white matter heterotopia are not required for seizure generation in this type II FCD model.
• Reducing FCD-related neuronal dysmorphogenesis, rather than correcting misplacement, is key to seizure suppression.
• Lifelong therapeutic interventions targeting developmental defects may be necessary for sustained seizure control in FCD-associated epilepsy.